Former Israeli Prime Minister Naftali Bennett has joined the board of Remepy, which is pioneering hybrid drugs that include therapeutic applications that enhance the drug effect.
The US consortium led by Michael Alpert has dropped out of the race while the Amir brothers offer to buy a controlling stake in the supermarket chain expires today.
After reporting strong fourth quarter results, the cybersecurity stock has now risen 1,658% in less than a decade, to become Israel's fifth most valuable company traded on Wall Street.
Accountant General Yali Rothenberg takes issue with Moody's credit rating cut, which did not take into account Israel's strong economic data, as the scale of the war is being reduced.
Governor of the Bank of Israel Amir Yaron says action must be taken to restore confidence in Israel's economy, but adds that it is capable of recovering rapidly after the war.